This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Top Research Reports for BP, Eaton & Manulife
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including BP p.l.c. (BP), Eaton (ETN) and Manulife Financial (MFC).
Cardinal (CAH) Upgraded to Strong Buy: Here's Why
by Zacks Equity Research
Cardinal (CAH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income - March 03, 2020
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
Top Ranked Momentum Stocks to Buy for March 3rd
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, March 3rd
New Strong Buy Stocks for March 3rd
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for today:
Is Cardinal Health (CAH) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (CAH) Outperforming Other Medical Stocks This Year?
Teladoc (TDOC) Hits New 52-Week High on Strong Q4 Results
by Zacks Equity Research
Teladoc (TDOC) reaches new 52-week high in the trading session on Feb 27 on impressive fourth-quarter results.
Zacks.com featured highlights include: McKesson, United Therapeutics, Virtusa and Cardinal Health
by Zacks Equity Research
Zacks.com featured highlights include: McKesson, United Therapeutics, Virtusa and Cardinal Health
4 Finest Value Stocks Based on Discounted PEG
by Urmimala Biswas
A lower PEG ratio, preferably less than 1, indicates both undervaluation and solid future growth potential of a stock.
Zacks.com featured highlights include: Cardinal Health, Anixter International, Abercrombie & Fitch, Brookdale Senior Living and Fluor
by Zacks Equity Research
Zacks.com featured highlights include: Cardinal Health, Anixter International, Abercrombie & Fitch, Brookdale Senior Living and Fluor
Top Ranked Income Stocks to Buy for February 26th
by Zacks Equity Research
Here are three stocks with buy rank and strong income characteristics for investors to consider today, February 26th.
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks - February 25, 2020
by Zacks Equity Research
The traditional approaches to retirement planning are longer covering all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
5 Broker-Friendly Stocks to Ride Out the Coronavirus Scare
by Maharathi Basu
One of the well-accepted investment policies is to maintain a diversified portfolio for reaping handsome returns, irrespective of the market volatility.
Should Value Investors Buy Cardinal Health (CAH) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Top Ranked Income Stocks to Buy for February 24th
by Zacks Equity Research
Here are three stocks with buy rank and strong income characteristics for investors to consider today, February 24th.
Looking for Value? Why It Might Be Time to Try Cardinal Health (CAH)
by Zacks Equity Research
Cardinal Health (CAH) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.
HealthEquity (HQY) Stock Up on Solid Fiscal 2020 Results
by Zacks Equity Research
HealthEquity (HQY) raises fiscal 2020 view for top and bottom line.
Baxter's Latest Acquisition to Boost Advanced Surgery Arm
by Zacks Equity Research
Baxter's (BAX) Advanced Surgery arm boasts of a wide spectrum of products.
Top Ranked Momentum Stocks to Buy for February 20th
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, February 20th.
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks - February 19, 2020
by Zacks Equity Research
The traditional approaches to retirement planning are longer covering all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
Zacks.com featured highlights include: DaVita, Legg Mason, PG&E, Cardinal Health and McKesson
by Zacks Equity Research
Zacks.com featured highlights include: DaVita, Legg Mason, PG&E, Cardinal Health and McKesson
Here's Why You Should Invest in Cardinal Health Stock Now
by Zacks Equity Research
Cardinal Health (CAH) is gaining from diversified product portfolio and robust pharmaceutical segment.
Here's Why You Should Add DaVita (DVA) to Your Portfolio Now
by Zacks Equity Research
DaVita (DVA) gains from solid results in the fourth quarter of 2019.
5 Great GARP Stocks Based on Discounted PEG
by Urmimala Biswas
PEG-based investing can be more rewarding with the addition of a few other relevant parameters.
Bleak Outlook for Medical Dental Supplies Industry
by Sreyoshi Mukherjee
Despite digital dentistry and AI being dominant market trends, near-term prospects of the Dental industry look dull.